Covalon's CovaClear Ag wound dressing cleared for marketing by FDA

By Angela McDaniels

Seattle, Feb. 7 - Covalon Technologies Ltd. said it has received marketing clearance from the Food and Drug Administration for CovaClear Ag Collagen with silver Antimicrobial Gel Sheet Dressing for full and partial thickness wounds.

The company said the product is unique in several regards:

• It is the only hydrated collagen-based silver ion-releasing dressing in the marketplace. Moist wound healing environments improve the healing process and reduce scarring, according to a company news release;

• It contains silver ion, which is a broad-spectrum antiseptic that allows the dressing to be an effective antimicrobial barrier; and

• The dressing is transparent and allows clinicians to monitor high-risk wounds without having to remove the dressing.

The global wound care market is more than $15 billion per year, the company said, and the U.S. market for moist dressings exceeds $500 million annually.

Covalon is a Mississauga, Ont.-based medical products company that develops therapeutic biomaterials for wound care and surgical applications and coatings.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.